BioSpace News Archive

Press Releases

PhenoNet, Inc. Completes Recruitment and Randomization in Phase IIb Clinical Trial Evaluating PHENOGENE-1A for Amyotrophic Lateral Sclerosis (ALS)

September 9, 2026
·
5 min read
Press Releases

TwoStep Therapeutics Announces Oversubscribed $62.5 Million Series A Financing and FDA Clearance of IND for First-in-Class Peptide-Drug Conjugate

September 9, 2026
·
5 min read
Press Releases

BioMarin Announces Positive Results of Phase 3 VOXZOGO® (vosoritide) Study in Hypochondroplasia Published in NEJM Evidence

September 9, 2026
·
11 min read
Press Releases

Rakuten Medical Appoints Christophe Weber as Vice Chairman and Ken Takeshita, M.D., as Director to Accelerate U.S. Growth and Oncology Innovation

September 9, 2026
·
6 min read
Press Releases

First Participant Dosed in First-in-Human Phase 1 Study of GZC8072, a Novel Ultra-Long-Acting Once-Weekly Oral Peptide GLP-1 RA

September 9, 2026
·
3 min read
Press Releases

Mighty Therapeutics Initiates IND-Enabling Studies of MYTX-255: a Mitochondrial-Targeted Therapeutic Candidate

September 9, 2026
·
3 min read
Press Releases

Three Chugai Researchers Behind the Discovery of Hemlibra for Hemophilia A Receive Prestigious U.S. Lasker Award, One of the World’s Most Respected Scientific Honors

September 9, 2026
·
16 min read
Press Releases

Novalix and OpenBench Partner to Create Fee-For-Success Drug Discovery for Life Science Organizations

September 9, 2026
·
1 min read
Press Releases

Massive Bio and PrecisCa Announce Strategic Partnership to Expand Cancer Patient Access to Clinical Trials Across the U.S.

September 9, 2026
·
4 min read
Press Releases

ImmunoGenesis Announces Appointment of Reza Mazhari and Mike Davis to Its Board of Directors

September 9, 2026
·
3 min read